7.580USD+1.20%Mkt Cap: 73.40M USDP/E: —Last update: 2026-06-01
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhanc…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap73.40M USD
Enterprise Value121.55M USD
Revenue (TTM)1.15M USD
Gross Profit-5.75M USD
Net Income (TTM)5.70M USD
Revenue/Share0.1260 USD
Last Price7.580 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees66
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.71
PEG—
EV/EBITDA-1.45
EV/Revenue105.97
P/S61.80
P/B2.65
EPS (TTM)-5.20
EPS (Forward)-10.28
52W Range
6.5604% of range29.98
52W High29.98 USD
52W Low6.560 USD
Profitability
Gross Margin-729.40%
Oper. Margin-5839.94%
EBITDA Margin0.00%
Profit Margin721.93%
ROE12.88%
ROA4.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF1.12M USD
CapEx (TTM)252.00K USD
FCF Margin-3621.47%
FCF Yield-56.59%
Net Debt50.66M USD
Net Debt/EBITDA-0.60
Balance Sheet
Debt/Equity1.88
Current Ratio1.65
Quick Ratio1.55
Book Value/Sh2.763 USD
Cash/Share3.081 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateApr 22, 2025
Analyst Consensus
Rating—
Target (Mean)22.00 USD
Target Range22.00 USD – 22.00 USD
# Analysts1
Ownership
Shares Out.9.68M
Float7.38M
Insiders11.78%
Institutions24.38%
Short Interest
Short Ratio9.5d
Short % Float6.93%
Short % Out.5.30%
Shares Short512.80K
Short (prev mo.)585.07K
Technical
SMA 508.237 (-8.0%)
SMA 20013.94 (-45.6%)
Beta0.12
S&P 52W Chg27.94%
Avg Vol (30d)43.47K
Avg Vol (10d)29.18K
Technical Indicators
RSI (14)43.1
MACD-0.1595
MACD Signal-0.1884
MACD Hist.+0.0289
BB Upper8.096 USD
BB Middle7.726 USD
BB Lower7.356 USD
BB Width9.58%
ATR (14)0.4888 USD
Vol Ratio (20d)0.82x